Skip to main content

Retinoblastoma Intra-arterial Chemotherapy

  • Chapter
  • First Online:
Interventional Neuroradiology

Abstract

Retinoblastoma is the most common intraocular tumor of childhood with an average age at diagnosis is 18 months. First-line intra-arterial chemotherapy is very promising for intraocular retinoblastoma and may be superior to intravenous chemotherapy or external beam radiotherapy. Intra-arterial chemotherapy is associated with tolerable systemic toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  • Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115(8):1398–404, 1404.e1.

    Article  PubMed  Google Scholar 

  • Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology. 2010a;117(8):1623–9.

    Article  PubMed  Google Scholar 

  • Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: tandem therapy. Arch Ophthalmol. 2010b;128(3):370–2.

    Article  PubMed  Google Scholar 

  • Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience. Arch Ophthalmol. 2011;129(6):732–7.

    Article  PubMed  Google Scholar 

  • Graeber CP, Gobin YP, Marr BP, et al. Histopathologic findings of eyes enucleated after treatment with chemosurgery for retinoblastoma. Open Ophthalmol J. 2011;5:1–5.

    Article  PubMed  Google Scholar 

  • Marr B, Gobin PY, Dunkel IJ, Brodie SE, Abramson DH. Spontaneously resolving periocular erythema and ciliary madarosis following intra-arterial chemotherapy for retinoblastoma. Middle East Afr J Ophthalmol. 2010;17(3):207–9.

    Article  PubMed  Google Scholar 

  • Patel M, Paulus YM, Gobin YP, et al. Intra-arterial and oral digoxin therapy for retinoblastoma. Ophthalmic Genet. 2011;32:147–50.

    Article  PubMed  CAS  Google Scholar 

  • Schefler AC, Abramson DH. Retinoblastoma: what is new in 2007–2008. Curr Opin Ophthalmol. 2008;19(6):526–34.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edward D. Greenberg MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Greenberg, E.D., Gobin, Y.P., Marr, B.P., Brodie, S.E., Dunkel, I.J., Abramson, D.H. (2014). Retinoblastoma Intra-arterial Chemotherapy. In: Murphy, K., Robertson, F. (eds) Interventional Neuroradiology. Techniques in Interventional Radiology. Springer, London. https://doi.org/10.1007/978-1-4471-4582-0_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4582-0_20

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4581-3

  • Online ISBN: 978-1-4471-4582-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics